Breast Cancer Disseminated Tumor Cells: Do They Stay and Fight or Run and Hide?

Area of Science:

• Immunology
• Cancer Biology
• Oncology

Background:

• Solid tumors, including breast cancer, can undergo early dissemination and dormancy.
• Disseminated tumor cells can survive undetected for years, potentially leading to late metastatic relapse.
• Understanding the immune system's role in regulating tumor cell dormancy is crucial for preventing metastasis.

Purpose of the Study:

• To investigate the role of Natural Killer (NK) cells in the immune surveillance of disseminated tumor cells.
• To elucidate the mechanisms by which dormant tumor cells resist NK-cell-mediated immunity.
• To explore the involvement of the STING pathway, Sox2, and Bach1 in immune evasion by disseminated tumor cells.

Main Methods:

• Utilized immunocompetent models to study tumor cell dormancy and immune interactions.
• Employed advanced technologies such as single-cell genomics and spatial transcriptomics.
• Analyzed the expression of MHC class I on disseminated and quiescent tumor cells.

Main Results:

• Disseminated and quiescent tumor cells exhibit increased expression of MHC class I.
• These tumor cells demonstrate resistance to NK-cell-mediated killing.
• The STING pathway, along with transcription factors Sox2 and Bach1, is implicated in this resistance mechanism.

Conclusions:

• NK cells play a significant role in controlling disseminated tumor cells.
• Dormant tumor cells employ mechanisms involving MHC-1 upregulation and the STING pathway to evade NK cell immunity.
• This study highlights the diverse immune strategies regulating tumor dormancy and necessitates further research into specific immune interactions.